
Results
25
Most Popular Stocks on the market
25 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.
CLN
zł21.00
7D
6.9%
1Y
-12.1%
Selvita
Market Cap: zł550.7m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł30.00
7D
-1.5%
1Y
-6.0%
Bioceltix
Market Cap: zł509.0m
Engages in the development of veterinary biologics based on mesenchymal stem cells.
BCX
zł93.50
7D
5.3%
1Y
-8.9%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł458.7m
A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.
CTX
zł74.90
7D
-0.8%
1Y
81.8%
Ryvu Therapeutics
Market Cap: zł353.7m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł14.98
7D
0.9%
1Y
-51.5%
BIOTON
Market Cap: zł328.9m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.84
7D
-0.3%
1Y
-8.3%
Synthaverse
Market Cap: zł207.2m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł2.72
7D
-3.2%
1Y
-47.6%
Mabion
Market Cap: zł120.6m
A biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.
MAB
zł7.62
7D
5.5%
1Y
-19.8%
Molecure
Market Cap: zł120.5m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.84
7D
3.0%
1Y
2.5%
Poltreg
Market Cap: zł114.2m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.70
7D
4.8%
1Y
-40.3%
NanoGroup
Market Cap: zł106.8m
Operates as a biotechnology company in Poland.
NNG
zł2.52
7D
3.1%
1Y
-4.6%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
Urteste
Market Cap: zł72.9m
Engages in the research and development of diagnostic tests for cancers.
URT
zł48.00
7D
0%
1Y
-2.6%
Genomtec
Market Cap: zł70.7m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł4.69
7D
-0.4%
1Y
-23.6%
Read-Gene
Market Cap: zł56.4m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł4.82
7D
4.8%
1Y
-7.3%
Biogened
Market Cap: zł45.4m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł18.40
7D
0.5%
1Y
-32.8%
Genomed Spólka Akcyjna
Market Cap: zł35.9m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł27.20
7D
-8.1%
1Y
5.4%
Medicofarma Biotech
Market Cap: zł28.3m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.41
7D
0.5%
1Y
47.7%
Pure Biologics
Market Cap: zł25.8m
A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.
PUR
zł2.16
7D
-0.7%
1Y
-54.1%
genXone
Market Cap: zł19.5m
Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
GX1
zł5.76
7D
-5.3%
1Y
-0.3%
Stem Cells Spin
Market Cap: zł16.9m
Operates as a biotechnology company in Poland.
SCS
zł0.41
7D
2.5%
1Y
45.4%
Green Zebras Spolka Akcyjna
Market Cap: zł15.0m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.40
7D
6.8%
1Y
6.8%
Cannabis Poland
Market Cap: zł13.2m
Operates in the medical cannabis industry in Poland.
CBD
zł0.18
7D
-0.6%
1Y
-44.2%
Tecnovatica
Market Cap: zł5.7m
Does not have significant operations.
TEC
zł0.53
7D
3.5%
1Y
28.8%
Labocanna
Market Cap: zł4.6m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.22
7D
-1.8%
1Y
-29.9%